TÜRKÇE
ENGLISH
Information
| Code | MEDF530 |
| Name | Radiopharmacy for Medical Physics |
| Term | 2023-2024 Academic Year |
| Term | Spring |
| Duration (T+A) | 3-0 (T-A) (17 Week) |
| ECTS | 6 ECTS |
| National Credit | 3 National Credit |
| Teaching Language | Türkçe |
| Level | Yüksek Lisans Dersi |
| Type | Normal |
| Mode of study | Yüz Yüze Öğretim |
| Catalog Information Coordinator | Prof.Dr. İSMAİL GÜNAY |
| Course Instructor |
1 |
Course Goal / Objective
Definition of radiopharmaceutical and radiopharmaceutical, preparation of radiopharmaceuticals, properties and usage.
Course Content
Radiopharmaceuticals / Nuclear Farm definition, radiopharmaceutical / radionuclide definition, basic information about drugs and pharmacology, production and use of radionuclides, jradionuclide generators, formulation of radiopharmaceuticals, properties of ideal radiopharmaceuticals physical properties and methods of localization, excretion, points to be considered in the use of radiopharmaceuticals, device use.
Course Precondition
none
Resources
Lecture notes (For Medical Faculty Students - İsmail Günay) Biophysics (Ferit Pehlivan) Biophysics (Gürbüz Çelebi) Internet Search
Notes
Internet Research
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Pharmacology, general information about drugs |
| LO02 | Know the definition and general concepts of radiopharmacy |
| LO03 | Learns the production methods and use of radionuclide |
| LO04 | Knows radiopharmaceuticals and their properties |
| LO05 | Know the radiopharmaceuticals and their properties |
| LO06 | Have knowledge about marking of radiopharmaceuticals and quality control |
| LO07 | Know the points to be considered in the use of radiopharmaceuticals |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Belirsiz | List and explain the functions of health organizations; explains how national and international health institutions are organized; explains how clinics are managed. | 3 |
| PLO02 | Belirsiz | Explains the technical infrastructure required for qualified service in the future of Medical Physics. | |
| PLO03 | Belirsiz | Explains the European Community and national legal frameworks, regulations, guides and codes of practice related to the subject of Medical Physics. | 2 |
| PLO04 | Belirsiz | Uses physical concepts, principles and theories in detail and numerically to explain structure, function, characteristics and limitations in fields covering Medical Physics; explains the use of medical devices in the field of medical physics. | |
| PLO05 | Belirsiz | Explains the properties of ionizing radiation (electromagnetic, electrons, ions, neutrons) and other physical agents (electric energy, static electricity/magnetic fields, non-ionizing electromagnetic radiation, vibration, sound and ultrasound, laser) in detail and quantitatively. | 3 |
| PLO06 | Belirsiz | Explains the beneficial and adverse/harmful biological effects of ionizing radiation and different physical agents associated with medical devices numerically with biological models. Explain the factors affecting the magnitude of the biological effect. Explains ways of manipulation to improve clinical outcomes. | 4 |
| PLO07 | Belirsiz | Explain deterministic/stochastic, early/late, teratogenic/genetic effects for each physical agent. | 3 |
| PLO08 | Belirsiz | Makes a list from the literature on General Physics, Medical Physics and Health Physics in order to systematically review something in the field of Medical Physics practice. | |
| PLO09 | Belirsiz | Applies the general concepts, principles and theories of physics to clinical problems related to the clinical use of medical devices, safety/risk management related to ionizing radiation. | 3 |
| PLO10 | Belirsiz | It uses the general concepts, principles and theories of physics to transfer new devices and related techniques to the clinical environment. | |
| PLO11 | Belirsiz | It uses statistical packages for the analysis of clinical and biomedical data. | 2 |
| PLO12 | Belirsiz | Defines and explains the various dosimetric quantities used; explains the relationship between dosimetric quantities (energy flux, kerma, absorbed dose). | |
| PLO13 | Belirsiz | Designs clinical and biomedical studies that are numerical and based on a rigorous statistical base. | 3 |
| PLO14 | Belirsiz | Determines the method during the delivery of ionizing radiation to the patient and designs different applications to improve this method. | 2 |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Definition of radiopharmacy, Farmasi, Pharmacology, General properties of drugs and drugs (routes of administration, pharmacokinetics etc.) | Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 2 | Atom, radioactivity, radiation, use of radioactivity, radioactivity applications in the field of health, development of radiopharmacy | 1Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 3 | Production, quality control and transportation of radiopharmaceuticals. Characteristics of radiopharmaceuticals used in diagnosis and treatment | 2Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 4 | Use of radiopharmaceuticals in treatment: General principles, Treatment of thyroid diseases. | 3Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 5 | Treatment of radiopharmaceuticals: Treatment of bone pain | 4Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 6 | Diagnostic use of radiopharmaceuticals: Central Nervous System | 5Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 7 | Diagnostic use of radiopharmaceuticals: Thyroid | 6Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 8 | Mid-Term Exam | Mid-Term Exam | Ölçme Yöntemleri: Yazılı Sınav |
| 9 | Diagnostic use of radiopharmaceuticals: Skeleton | 7Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 10 | Diagnostic use of radiopharmaceuticals: heart and lung | 8Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 11 | Diagnostic use of radiopharmaceuticals: Tumor imaging | 9Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 12 | Diagnostic use of radiopharmaceuticals: Liver, spleen, kidney and other organs | 10Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 13 | Properties of specific radiopharmaceuticals: Phenheum-labeled radiopharmaceuticals | 11Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 14 | Properties of specific radiopharmaceuticals: Iodine, phosphorus, gallium and other radiopharmaceuticals | 12Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 15 | Properties of specific radiopharmaceuticals: Pet radiopharmaceuticals | 13Reading from the recommended book | Öğretim Yöntemleri: Anlatım, Gösteri |
| 16 | Term Exams | Term Exams | Ölçme Yöntemleri: Sözlü Sınav, Ödev |
| 17 | Term Exams | Term Exams | Ölçme Yöntemleri: Yazılı Sınav, Ödev |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 3 | 42 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 5 | 70 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 0 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 15 | 15 |
| Final Exam | 1 | 30 | 30 |
| Total Workload (Hour) | 157 | ||
| Total Workload / 25 (h) | 6,28 | ||
| ECTS | 6 ECTS | ||